Haleon Net Total Equity Issued/Repurchased 2023-2024 | HLN

Haleon annual/quarterly net total equity issued/repurchased history and growth rate from 2023 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
  • Haleon net total equity issued/repurchased for the quarter ending September 30, 2024 was $0M, a 100% decline year-over-year.
  • Haleon net total equity issued/repurchased for the twelve months ending September 30, 2024 was $0M, a 100% decline year-over-year.
  • Haleon annual net total equity issued/repurchased for 2024 was $-0.797B, a 1587% increase from 2023.
  • Haleon annual net total equity issued/repurchased for 2023 was $-0.047B, a 312.31% decline from 2022.
  • Haleon annual net total equity issued/repurchased for 2022 was $0.022B, a 0% decline from 2021.
Haleon Annual Net Total Equity Issued/Repurchased
(Millions of US $)
2024 $-797
2023 $-47
2022 $22
2021 $N/A
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $48.101B $14.355B
Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.007B 27.90
Boston Scientific (BSX) United States $155.135B 38.84
Stryker (SYK) United States $149.698B 31.30
EssilorLuxottica (ESLOY) France $129.877B 0.00
Medtronic (MDT) Ireland $110.440B 16.12
Lonza Group Ag (LZAGY) Switzerland $48.984B 0.00
ResMed (RMD) United States $36.449B 27.38
GE HealthCare Technologies (GEHC) United States $33.384B 15.85
Agilent Technologies (A) United States $32.046B 21.17
Terumo (TRUMY) Japan $27.153B 35.27
Koninklijke Philips (PHG) Netherlands $22.822B 16.41
Insulet (PODD) United States $22.662B 88.96
Zimmer Biomet Holdings (ZBH) United States $19.138B 12.29
Baxter (BAX) United States $15.929B 11.89
Smith & Nephew SNATS (SNN) United Kingdom $12.591B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.618B 23.03
Lantheus Holdings (LNTH) United States $5.520B 13.92
Prestige Consumer Healthcare (PBH) United States $4.305B 19.23
Perrigo (PRGO) Ireland $3.614B 9.16
Haemonetics (HAE) United States $3.485B 15.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.459B 25.51
Envista Holdings (NVST) United States $3.066B 25.48
QuidelOrtho (QDEL) United States $2.234B 15.36
GN Store Nord (GNNDY) Denmark $2.150B 17.81
LeMaitre Vascular (LMAT) United States $1.882B 42.07
AtriCure (ATRC) United States $1.599B 0.00
Neogen (NEOG) United States $1.424B 18.22
AdaptHealth (AHCO) United States $1.220B 12.38
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
Green Thumb Industries (GTBIF) United States $1.209B 27.19
BioLife Solutions (BLFS) United States $1.045B 0.00
InMode (INMD) Israel $1.023B 9.37
Phibro Animal Health (PAHC) United States $0.966B 12.35
Evolus (EOLS) United States $0.645B 0.00
CeriBell (CBLL) United States $0.636B 0.00
Curaleaf Holdings (CURLF) Canada $0.586B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
Valneva SE (VALN) France $0.516B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.499B 0.00
Tilray Brands (TLRY) Canada $0.443B 0.00
Capricor Therapeutics (CAPR) United States $0.437B 0.00
Surmodics (SRDX) United States $0.401B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.95
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Aurora Cannabis (ACB) Canada $0.279B 49.60
Sanara MedTech (SMTI) United States $0.274B 0.00
Verano Holdings (VRNOF) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Cerus (CERS) United States $0.247B 0.00
Canopy Growth (CGC) Canada $0.246B 0.00
ZimVie (ZIMV) United States $0.242B 11.00
Omeros (OMER) United States $0.230B 0.00
Biote (BTMD) United States $0.220B 6.18
Brainsway (BWAY) Israel $0.188B 49.90
High Tide (HITI) Canada $0.187B 0.00
OraSure Technologies (OSUR) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.51
Quanterix (QTRX) United States $0.175B 0.00
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Jin Medical (ZJYL) China $0.129B 0.00
TerrAscend (TSNDF) Canada $0.128B 0.00
Exagen (XGN) United States $0.122B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Fonar (FONR) United States $0.084B 10.83
Veru (VERU) United States $0.075B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Quipt Home Medical (QIPT) United States $0.065B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 13.00
Rockwell Medical (RMTI) United States $0.033B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.023B 30.57
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.019B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00